The Short-Sighted, $27 Billion U.S. EV Retreat

This week’s Current Climate newsletter also looks at Brightline’s rising bullet train costs and how Ecolab is solving the data center water problem.

Investors Put More Than $55 Billion Behind Space Startups Last Year

In this week’s edition of The Prototype, we look at the booming space industry, better space weather forecasts, the first medical evacuation from space and more.

Warehouse With $35 Million Of Apple Devices Linked To Chinese Fraud Ring

DHS has been investigating a sprawling fraud operation where Chinese criminals have been buying iPhones and iPads with funds from scams, including sextortion and romance swindles.

Inside The J.P. Morgan Healthcare Extravaganza

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and Lilly’s $1 billion AI venture, and more.

Brightline Hires Ex-Eurostar Chief As Vegas Bullet Train Costs Climb

Nicolas Petrovic, who led the London-Paris-Brussels train systems, will oversee the company’s expanding Florida operations and the first U.S. high-speed railway.

AI Fraud Has Exploded. This Background-Check Startup Is Cashing In.

San Francisco-based Checkr has seen its revenues jump 14% to $800 million as companies try to spot a flood of AI-generated CVs and faked financial documents.

The U.S. Goes Rogue On The Climate Fight

This week’s Current Climate newsletter also looks at the AI boom’s water problem and stabilized funding for the California High-Speed Rail project.

Thai Billionaire Harald Link’s B.Grimm Power Buys $230 Million Stake In U.S. Hydropower Operator

B.Grimm Power—controlled by Thai billionaire Harald Link—has bought a stake in U.S.-based hydropower operator New England Reliable Hydropower Holdings for 7.24 billion baht ($230 million) amid the group’s drive to expand its overseas renewable energy p…

A ‘Holy Grail’ Sleep Apnea Pill Could Be On The Market Next Year

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.